Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 26;397(10293):2461-2462.
doi: 10.1016/S0140-6736(21)01358-1. Epub 2021 Jun 14.

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

Aziz Sheikh  1 , Jim McMenamin  2 , Bob Taylor  2 , Chris Robertson  2 ; Public Health Scotland and the EAVE II Collaborators
Affiliations

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

Aziz Sheikh et al. Lancet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

AS, JM, and CR are members of the Scottish Government's COVID-19 Advisory Group. AS and CR are members of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) risk stratification subgroup. JM is a member of NERVTAG. CR is a member of the Scientific Pandemic Influenza Group on Modelling. AS is a member of AstraZeneca's Thrombotic Thrombocytopenic Advisory Group. All roles are unremunerated. JM, BT, and CR are employed by Public Health Scotland. Acknowledgments are listed in the appendix.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Simpson CR, Robertson C, Vasileiou E, et al. Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data. BMJ Open. 2020;10 - PMC - PubMed
    1. Mulholland RH, Vasileiou E, Simpson CR, et al. Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database. Int J Epidemiol. 2021 doi: 10.1093/ije/dyab028. published online April 16. - DOI - PMC - PubMed
    1. Vasileiou E, Simpson CR, Shi T, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021;397:1646–1657. - PMC - PubMed
    1. Simpson CR, Shi T, Vasileiou E, et al. First dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and haemorrhagic events in Scotland. Nat Med. 2021 doi: 10.1038/s41591-021-01408-4. published online June 9. - DOI - PMC - PubMed
    1. Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373 - PMC - PubMed

Substances